AA
Abdulrashid Abdulmajid Mall
About Abdulrashid Abdulmajid Mall
Data last updated:
Abdulrashid Abdulmajid Mall has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Unimedia Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Unimedia Pharmaceuticals Private Limited at ₹1.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unimedia Pharmaceuticals Private Limited U24233GJ2013PTC074110 | Director | 21 Mar 2013 | 2013 | ₹1.73 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdulrashid Abdulmajid Mall
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdulrashid Abdulmajid Mall
Abdulrashid Abdulmajid Mall has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Unimedia Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Unimedia Pharmaceuticals Private Limited at ₹1.73 Cr (FY 2025).
Abdulrashid Abdulmajid Mall is associated with 1 company as Director, including Unimedia Pharmaceuticals Private Limited (₹1.73 Cr).
Abdulrashid Abdulmajid Mall has expertise in General Business.
Abdulrashid Abdulmajid Mall has 13 years in corporate governance.
By reported revenue, the largest current company of Abdulrashid Abdulmajid Mall is Unimedia Pharmaceuticals Private Limited, with revenue of ₹1.73 Cr (FY 2025).
Abdulrashid Abdulmajid Mall currently holds positions at 1 company: Unimedia Pharmaceuticals Private Limited (₹1.73 Cr).